Tekla Capital Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$6.29M	Hold	154,269	–	–	0.25%	77
2023 Q1	$5.75M	Hold	154,269	–	–	0.22%	75
2022 Q4	$5.38M	Hold	154,269	–	–	0.2%	76
2022 Q3	$8.63M	Buy	154,269 +96,089	+165%	+$5.38M	0.35%	58
2022 Q2	$3.01M	Hold	58,180	–	–	0.12%	103
2022 Q1	$4.23M	Hold	58,180	–	–	0.15%	101
2021 Q4	$6.88M	Hold	58,180	–	–	0.22%	86
2021 Q3	$7.81M	Hold	58,180	–	–	0.25%	85
2021 Q2	$9.42M	Buy	58,180 +5,000	+9%	+$810K	0.31%	85
2021 Q1	$4.27M	Buy	+53,180	New	+$4.27M	0.15%	125
2020 Q3	–	Sell	-55,050	Closed	-$1.16M	–	215
2020 Q2	$1.16M	Hold	55,050	–	–	0.04%	189
2020 Q1	$673K	Hold	55,050	–	–	0.03%	188
2019 Q4	$808K	Hold	55,050	–	–	0.03%	182
2019 Q3	$735K	Sell	55,050 -95,240	-63%	-$1.27M	0.03%	169
2019 Q2	$2.46M	Hold	150,290	–	–	0.1%	124
2019 Q1	$2.57M	Hold	150,290	–	–	0.1%	122
2018 Q4	$2.05M	Buy	150,290 +81,619	+119%	+$1.11M	0.09%	128
2018 Q3	$1.97M	Sell	68,671 -98,710	-59%	-$2.82M	0.07%	156
2018 Q2	$4.58M	Hold	167,381	–	–	0.17%	97
2018 Q1	$3.53M	Buy	+167,381	New	+$3.53M	0.14%	108
2017 Q3	–	Sell	-28,000	Closed	-$448K	–	157
2017 Q2	$448K	Sell	28,000 -43,842	-61%	-$701K	0.02%	138
2017 Q1	$1.01M	Hold	71,842	–	–	0.04%	126
2016 Q4	$942K	Hold	71,842	–	–	0.04%	130
2016 Q3	$1.22M	Sell	71,842 -15,000	-17%	-$255K	0.05%	130
2016 Q2	$1.85M	Buy	+86,842	New	+$1.85M	0.08%	118